Potential Economic Viability of Two Proposed Rifapentine-Based Regimens for Treatment of Latent Tuberculosis Infection

• David P. Holland ,

  * E-mail: david.p.holland@duke.edu

  Affiliations Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Gillian D. Sanders,

  Affiliation Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Carol D. Hamilton,

  Affiliations Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, United States of America, Family Health International, Research Triangle Park, North Carolina, United States of America

  ⨯
• Jason E. Stout

  Affiliations Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯